Proteq West Nile 2x1 dose EU
Le numéro d’autorisation de mise sur le marché de votre pays ne pas répertorié ? Il s'agit alors d'un produit cascade. Cliquez ici pour plus d'informations.
Active immunisation of horses from 5 months of age against West Nile disease by reducing the number of viraemic horses. If clinical signs are present, their duration and severity are reduced.
Indications d'utilisation
Onset of immunity: 4 weeks after the first dose of the primary vaccination course. In order to achieve full protection, the full vaccination course of two doses must be given.
Duration of immunity: 1 year after a full primary vaccination course of two injections.
Active ingredient: West Nile recombinant canarypox virus (vCP2017) 6.0 to 7.8 log10 CCID*50
* Cell culture infectious dose 50 %
Adjuvant: Carbomer 4mg
Additional ingredients: Sodium chloride, Disodium phosphate dihydrate, Potassium dihydrogen phosphate, Water for injections
Conseils vétérinaires
Store and transport refrigerated (2 °C-8 °C)
Do not freeze
Protect from light